Bicycle Therapeutics Plc (BCYC)
4.50
-0.18
(-3.85%)
USD |
NASDAQ |
Mar 26, 16:00
4.37
-0.13
(-2.89%)
After-Hours: 16:39
Bicycle Therapeutics Free Cash Flow : -252.61M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -14.30M |
| Mereo BioPharma Group Plc | -31.36M |
| Autolus Therapeutics Plc | -306.93M |
| DBV Technologies SA | -98.65M |
| Cellectis SA | -43.68M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.10M |
| Cash from Investing (Quarterly) | -0.5731M |
| Cash from Financing (Quarterly) | -0.0149M |
| Free Cash Flow Per Share (Quarterly) | -0.2836 |
| Free Cash Flow to Equity (Quarterly) | -30.71M |
| Free Cash Flow to Firm (Quarterly) | -19.63M |
| Free Cash Flow Yield | -81.03% |